Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.Biorxiv : the Preprint Server for Biology|March 3, 2021
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.Science Advances|October 5, 2022
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibodySanjeev Kumar, Anamika Patel, Lilin Lai, et al.Cell Host & Microbe|April 2, 2021
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapid generation of neutralizing antibody responses in COVID-19 patientsMehul S Suthar, Matthew Zimmerman, Robert Kauffman, et al.Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.Cell Reports. Medicine|August 25, 2020
Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsMehul S Suthar, Matthew G Zimmerman, Robert C Kauffman, et al.Pageof 4